newsfilter
← Latest News
GlobeNewswire·

Avalo Therapeutics to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference

WAYNE, Pa. and ROCKVILLE, Md. , Feb. 04, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ:AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced that